For the year ending 2025-12-31.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| General and administrative | 53,026 | |||
| Professional fees | 23,372 | |||
| Total operating expenses | 76,398 | |||
| Loss from operations | -76,398 | |||
| Loss before provision for income taxes | -76,398 | |||
| Net loss | -76,398 | |||
| Basic EPS | 0 | |||
| Diluted EPS | 0 | |||
| Basic Average Shares | 1,047,549,224 | |||
| Diluted Average Shares | 1,047,549,224 | |||
NIKA PHARMACEUTICALS, INC (NIKA)
NIKA PHARMACEUTICALS, INC (NIKA)